These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 18055422

  • 1. Stimulation of the hypothalamic-pituitary-adrenal axis with corticotropin releasing hormone in patients with psoriasis.
    Karanikas E, Harsoulis F, Giouzepas I, Griveas I.
    Hormones (Athens); 2007; 6(4):314-20. PubMed ID: 18055422
    [Abstract] [Full Text] [Related]

  • 2. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.
    Pivonello R, Faggiano A, Filippella M, Di Somma C, De Martino MC, Gaccione M, Lombardi G, Colao A.
    J Endocrinol Invest; 2002 Dec; 25(11):932-7. PubMed ID: 12553551
    [Abstract] [Full Text] [Related]

  • 4. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 5. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function.
    Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):848-53. PubMed ID: 8077372
    [Abstract] [Full Text] [Related]

  • 6. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S, Wichers M, Klingmüller D, Höfer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stüber F.
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [Abstract] [Full Text] [Related]

  • 7. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome.
    Lanzone A, Petraglia F, Fulghesu AM, Ciampelli M, Caruso A, Mancuso S.
    Fertil Steril; 1995 Jun; 63(6):1195-9. PubMed ID: 7750588
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ, Ellis MJ, Evans MJ, Donald RA.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [Abstract] [Full Text] [Related]

  • 10. Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's disease.
    Cannavò S, Li Calzi L, Aragona A, Trimarchi F.
    J Endocrinol Invest; 1988 Jun; 11(6):425-8. PubMed ID: 2850311
    [Abstract] [Full Text] [Related]

  • 11. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone.
    Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP.
    Neuroendocrinology; 1992 May; 55(5):600-8. PubMed ID: 1350069
    [Abstract] [Full Text] [Related]

  • 12. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J, Balm PH, Ruane NM, Pérez-Sánchez J, Wendelaar-Bonga SE, Tort L.
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [Abstract] [Full Text] [Related]

  • 13. Neuroendocrine stimulatory tests of hypothalamus-pituitary-adrenal axis in psoriasis and correlative implications with psychopathological and immune parameters.
    Karanikas E, Harsoulis F, Giouzepas I, Griveas I, Chrisomallis F.
    J Dermatol; 2009 Jan; 36(1):35-44. PubMed ID: 19207435
    [Abstract] [Full Text] [Related]

  • 14. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
    Alexander SL, Irvine CH, Donald RA.
    Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
    [Abstract] [Full Text] [Related]

  • 15. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y, Spangler R, Schlussman SD, Ho A, Kreek MJ.
    Brain Res; 2003 Feb 28; 964(2):187-99. PubMed ID: 12576179
    [Abstract] [Full Text] [Related]

  • 16. Hormonal interactions within the hypothalamus and pituitary with respect to stress and reproduction in sheep.
    Smith RF, Dobson H.
    Domest Anim Endocrinol; 2002 Jul 28; 23(1-2):75-85. PubMed ID: 12142228
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
    Kuperman H, Damiani D, Chrousos GP, Dichtchekenian V, Manna TD, Filho VO, Setian N.
    J Clin Endocrinol Metab; 2001 Jul 28; 86(7):2993-6. PubMed ID: 11443157
    [Abstract] [Full Text] [Related]

  • 18. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome.
    Gomez MT, Magiakou MA, Mastorakos G, Chrousos GP.
    J Clin Endocrinol Metab; 1993 Jul 28; 77(1):173-7. PubMed ID: 8392083
    [Abstract] [Full Text] [Related]

  • 19. Low dose (1 microg) adrenocorticotropin stimulation test in the evaluation of hypothalamo-pituitary-adrenal axis in patients with active pulmonary tuberculosis.
    Keleştimur F, Göktaş Z, Gülmez I, Unlühizarci K, Bayram F, Ozesmi M, Güven M, Tutuş A.
    J Endocrinol Invest; 2000 Apr 28; 23(4):235-9. PubMed ID: 10853709
    [Abstract] [Full Text] [Related]

  • 20. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y, Aguilera G.
    Neuroendocrinology; 1992 Nov 28; 56(5):611-8. PubMed ID: 1336816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.